001     154384
005     20240229123059.0
024 7 _ |a 10.1001/jamaoncol.2020.0421
|2 doi
024 7 _ |a pmid:32239218
|2 pmid
024 7 _ |a 2374-2437
|2 ISSN
024 7 _ |a 2374-2445
|2 ISSN
024 7 _ |a altmetric:78845575
|2 altmetric
037 _ _ |a DKFZ-2020-00724
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Babic, Ana
|b 0
245 _ _ |a Association Between Breastfeeding and Ovarian Cancer Risk.
260 _ _ |a Chicago, Ill.
|c 2020
|b American Medical Association
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1600264049_19384
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Breastfeeding has been associated with a reduced risk of epithelial ovarian cancer in multiple studies, but others showed no association. Whether risk reduction extends beyond that provided by pregnancy alone or differs by histotype is unclear. Furthermore, the observed associations between duration and timing of breastfeeding with ovarian cancer risk have been inconsistent.To determine the association between breastfeeding (ie, ever/never, duration, timing) and ovarian cancer risk overall and by histotype.A pooled analysis of parous women with ovarian cancer and controls from 13 case-control studies participating in the Ovarian Cancer Association Consortium was performed. Odds ratios (ORs) and 95% CIs of the overall association were calculated using multivariable logistic regression and polytomous logistic regression for histotype-specific associations. All data were collected from individual sites from November 1989 to December 2009, and analysis took place from September 2017 to July 2019.Data on breastfeeding history, including duration per child breastfed, age at first and last breastfeeding, and years since last breastfeeding were collected by questionnaire or interview and was harmonized across studies.Diagnosis of epithelial ovarian cancer.A total of 9973 women with ovarian cancer (mean [SD] age, 57.4 [11.1] years) and 13 843 controls (mean [SD] age, 56.4 [11.7] years) were included. Breastfeeding was associated with a 24% lower risk of invasive ovarian cancer (odds ratio [OR], 0.76; 95% CI, 0.71-0.80). Independent of parity, ever having breastfed was associated with reduction in risk of all invasive ovarian cancers, particularly high-grade serous and endometrioid cancers. For a single breastfeeding episode, mean breastfeeding duration of 1 to 3 months was associated with 18% lower risk (OR, 0.82; 95% CI, 0.76-0.88), and breastfeeding for 12 or more months was associated with a 34% lower risk (OR, 0.66; 95% CI, 0.58-0.75). More recent breastfeeding was associated with a reduction in risk (OR, 0.56; 95% CI, 0.47-0.66 for <10 years) that persisted for decades (OR, 0.83; 95% CI, 0.77-0.90 for ≥30 years; P for trend = .02).Breastfeeding is associated with a significant decrease in risk of ovarian cancer overall and for the high-grade serous subtype, the most lethal type of ovarian cancer. The findings suggest that breastfeeding is a potentially modifiable factor that may lower risk of ovarian cancer independent of pregnancy alone.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Sasamoto, Naoko
|b 1
700 1 _ |a Rosner, Bernard A
|b 2
700 1 _ |a Tworoger, Shelley S
|b 3
700 1 _ |a Jordan, Susan J
|b 4
700 1 _ |a Risch, Harvey A
|b 5
700 1 _ |a Harris, Holly R
|b 6
700 1 _ |a Rossing, Mary Anne
|b 7
700 1 _ |a Doherty, Jennifer A
|b 8
700 1 _ |a Fortner, Renée T
|0 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2
|b 9
|u dkfz
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 10
|u dkfz
700 1 _ |a Goodman, Marc T
|b 11
700 1 _ |a Thompson, Pamela J
|b 12
700 1 _ |a Moysich, Kirsten B
|b 13
700 1 _ |a Ness, Roberta B
|b 14
700 1 _ |a Kjaer, Susanne K
|b 15
700 1 _ |a Jensen, Allan
|b 16
700 1 _ |a Schildkraut, Joellen M
|b 17
700 1 _ |a Titus, Linda J
|b 18
700 1 _ |a Cramer, Daniel W
|b 19
700 1 _ |a Bandera, Elisa V
|b 20
700 1 _ |a Qin, Bo
|b 21
700 1 _ |a Sieh, Weiva
|b 22
700 1 _ |a McGuire, Valerie
|b 23
700 1 _ |a Sutphen, Rebecca
|b 24
700 1 _ |a Pearce, Celeste L
|b 25
700 1 _ |a Wu, Anna H
|b 26
700 1 _ |a Pike, Malcolm
|b 27
700 1 _ |a Webb, Penelope M
|b 28
700 1 _ |a Modugno, Francesmary
|b 29
700 1 _ |a Terry, Kathryn L
|b 30
773 _ _ |a 10.1001/jamaoncol.2020.0421
|g p. e200421 -
|0 PERI:(DE-600)2810928-4
|n 6
|p e200421
|t JAMA oncology
|v 6
|y 2020
|x 2374-2437
909 C O |p VDB
|o oai:inrepo02.dkfz.de:154384
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b JAMA ONCOL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b JAMA ONCOL : 2017
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21